| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 5.63e-10 | 35 | 56 | 6 | GO:0015020 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 4.34e-06 | 153 | 56 | 6 | GO:0008194 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 2.71e-05 | 211 | 56 | 6 | GO:0016758 | |
| GeneOntologyMolecularFunction | retinoic acid binding | 6.51e-05 | 28 | 56 | 3 | GO:0001972 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 1.51e-04 | 288 | 56 | 6 | GO:0016757 | |
| GeneOntologyMolecularFunction | retinoid binding | 3.30e-04 | 48 | 56 | 3 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 3.51e-04 | 49 | 56 | 3 | GO:0019840 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 1.52e-03 | 446 | 56 | 6 | GO:0004674 | |
| GeneOntologyBiologicalProcess | biphenyl catabolic process | 9.47e-15 | 8 | 57 | 6 | GO:0070980 | |
| GeneOntologyBiologicalProcess | biphenyl metabolic process | 7.07e-14 | 10 | 57 | 6 | GO:0018879 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 3.10e-13 | 12 | 57 | 6 | GO:0052697 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 1.78e-11 | 21 | 57 | 6 | GO:0052695 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 7.49e-11 | 26 | 57 | 6 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 7.49e-11 | 26 | 57 | 6 | GO:0006063 | |
| GeneOntologyBiologicalProcess | benzene-containing compound metabolic process | 7.39e-10 | 37 | 57 | 6 | GO:0042537 | |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 7.39e-10 | 37 | 57 | 6 | GO:0042178 | |
| GeneOntologyBiologicalProcess | androgen metabolic process | 8.76e-10 | 38 | 57 | 6 | GO:0008209 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 6.27e-09 | 52 | 57 | 6 | GO:0008210 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 2.50e-06 | 141 | 57 | 6 | GO:0006805 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | 1.34e-05 | 286 | 57 | 7 | GO:0042445 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 3.34e-05 | 222 | 57 | 6 | GO:0071466 | |
| GeneOntologyBiologicalProcess | cellular catabolic process | TLK2 MVB12A LONP2 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B28 EIF2AK1 UGT2B11 IL4I1 | 5.53e-04 | 1253 | 57 | 11 | GO:0044248 |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle fusion to presynaptic active zone membrane | 5.74e-04 | 13 | 57 | 2 | GO:0031632 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle membrane organization | 5.74e-04 | 13 | 57 | 2 | GO:1901634 | |
| GeneOntologyBiologicalProcess | calcium-dependent activation of synaptic vesicle fusion | 5.74e-04 | 13 | 57 | 2 | GO:0099502 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | 5.84e-04 | 376 | 57 | 6 | GO:0008202 | |
| GeneOntologyCellularComponent | nuclear outer membrane | 8.01e-10 | 40 | 54 | 6 | GO:0005640 | |
| GeneOntologyCellularComponent | nuclear membrane | 3.07e-05 | 349 | 54 | 7 | GO:0031965 | |
| GeneOntologyCellularComponent | organelle outer membrane | 8.08e-05 | 279 | 54 | 6 | GO:0031968 | |
| GeneOntologyCellularComponent | outer membrane | 8.41e-05 | 281 | 54 | 6 | GO:0019867 | |
| GeneOntologyCellularComponent | nuclear envelope | 5.67e-04 | 560 | 54 | 7 | GO:0005635 | |
| MousePheno | enlarged stomach | 2.70e-06 | 33 | 42 | 4 | MP:0003883 | |
| MousePheno | abnormal eye anterior chamber morphology | 9.44e-05 | 80 | 42 | 4 | MP:0005205 | |
| Domain | UDPGT | 3.23e-11 | 21 | 57 | 6 | PS00375 | |
| Domain | UDPGT | 3.23e-11 | 21 | 57 | 6 | PF00201 | |
| Domain | UDP_glucos_trans | 3.23e-11 | 21 | 57 | 6 | IPR002213 | |
| Domain | Ank_2 | 4.97e-04 | 215 | 57 | 5 | PF12796 | |
| Domain | Ank | 6.48e-04 | 228 | 57 | 5 | PF00023 | |
| Domain | - | 9.46e-04 | 248 | 57 | 5 | 1.25.40.20 | |
| Domain | ANK | 9.98e-04 | 251 | 57 | 5 | SM00248 | |
| Domain | ANK_REPEAT | 1.03e-03 | 253 | 57 | 5 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 1.05e-03 | 254 | 57 | 5 | IPR020683 | |
| Domain | ANK_REP_REGION | 1.05e-03 | 254 | 57 | 5 | PS50297 | |
| Domain | Ankyrin_rpt | 1.21e-03 | 262 | 57 | 5 | IPR002110 | |
| Domain | Ribosomal_S5_D2-typ_fold | 4.82e-03 | 34 | 57 | 2 | IPR020568 | |
| Domain | PROTEIN_KINASE_ST | 4.88e-03 | 362 | 57 | 5 | PS00108 | |
| Domain | Kinase-like_dom | 6.02e-03 | 542 | 57 | 6 | IPR011009 | |
| Domain | Pkinase | 6.04e-03 | 381 | 57 | 5 | PF00069 | |
| Pathway | REACTOME_PREDNISONE_ADME | 4.02e-11 | 23 | 41 | 6 | MM16639 | |
| Pathway | REACTOME_GLUCURONIDATION | 5.35e-11 | 24 | 41 | 6 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 7.02e-11 | 25 | 41 | 6 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 7.02e-11 | 25 | 41 | 6 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 7.02e-11 | 25 | 41 | 6 | M605 | |
| Pathway | WP_GLUCURONIDATION | 9.11e-11 | 26 | 41 | 6 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 1.48e-10 | 28 | 41 | 6 | M19580 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 1.26e-09 | 39 | 41 | 6 | MM15695 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 1.72e-09 | 41 | 41 | 6 | M7399 | |
| Pathway | REACTOME_ASPIRIN_ADME | 2.69e-09 | 44 | 41 | 6 | M45014 | |
| Pathway | REACTOME_ASPIRIN_ADME | 3.10e-09 | 45 | 41 | 6 | MM15694 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 6.76e-09 | 51 | 41 | 6 | M17726 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 7.62e-09 | 52 | 41 | 6 | M14171 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 1.08e-08 | 55 | 41 | 6 | M14933 | |
| Pathway | KEGG_RETINOL_METABOLISM | 2.74e-08 | 64 | 41 | 6 | M9488 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 4.72e-08 | 70 | 41 | 6 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 5.60e-08 | 72 | 41 | 6 | M9257 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | UGT2B4 UGT2B7 UGT2B10 UGT2B15 NCOA1 UGT2B28 UGT2B11 HSP90AB1 | 1.84e-07 | 219 | 41 | 8 | MM14838 |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | UGT2B4 UGT2B7 UGT2B10 UGT2B15 NCOA1 UGT2B28 UGT2B11 HSP90AB1 | 1.90e-07 | 220 | 41 | 8 | M10320 |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 6.02e-07 | 107 | 41 | 6 | MM14595 | |
| Pathway | REACTOME_DRUG_ADME | 6.71e-07 | 109 | 41 | 6 | M45012 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 6.71e-07 | 109 | 41 | 6 | M18788 | |
| Pathway | REACTOME_DRUG_ADME | 1.13e-06 | 119 | 41 | 6 | MM15692 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 1.79e-04 | 183 | 41 | 5 | M39588 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 7.35e-04 | 14 | 41 | 2 | M39328 | |
| Pathway | WP_TAMOXIFEN_METABOLISM | 1.67e-03 | 21 | 41 | 2 | M39631 | |
| Pubmed | 1.42e-16 | 7 | 60 | 6 | 26074487 | ||
| Pubmed | 5.69e-16 | 8 | 60 | 6 | 32093886 | ||
| Pubmed | Expression of testicular germ cell genes identified by differential display analysis. | 5.57e-10 | 8 | 60 | 4 | 12634303 | |
| Pubmed | 5.57e-10 | 8 | 60 | 4 | 10748067 | ||
| Pubmed | 4.88e-09 | 3 | 60 | 3 | 7835904 | ||
| Pubmed | 4.88e-09 | 3 | 60 | 3 | 8333863 | ||
| Pubmed | 1.95e-08 | 4 | 60 | 3 | 10024527 | ||
| Pubmed | 4.87e-08 | 5 | 60 | 3 | 15318931 | ||
| Pubmed | 1.06e-07 | 66 | 60 | 5 | 19898482 | ||
| Pubmed | 2.72e-07 | 8 | 60 | 3 | 18719240 | ||
| Pubmed | 2.72e-07 | 8 | 60 | 3 | 20142249 | ||
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | RPL10A PHF2 CASP8AP2 MVB12A ARID4B CLK3 GLG1 NCOA1 PDIA5 ZBTB18 HSP90AB1 | 4.48e-07 | 922 | 60 | 11 | 27609421 |
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 1.06e-06 | 12 | 60 | 3 | 20308471 | |
| Pubmed | 1.06e-06 | 12 | 60 | 3 | 18161889 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 17263731 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 10222050 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 21679149 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 15319348 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 28962835 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 17687269 | ||
| Pubmed | 3.47e-06 | 370 | 60 | 7 | 15164053 | ||
| Pubmed | 3.91e-06 | 18 | 60 | 3 | 20056724 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 19572376 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 18496127 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 23223495 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 27098059 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 22092298 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 29138287 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 28882566 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 32176075 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 16849011 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 26176234 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 26238215 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 11036079 | ||
| Pubmed | 4.43e-05 | 225 | 60 | 5 | 12168954 | ||
| Pubmed | 6.11e-05 | 7 | 60 | 2 | 16513443 | ||
| Pubmed | 6.11e-05 | 7 | 60 | 2 | 20056642 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RPL10A PHF2 WDR3 CASP8AP2 SETX ARID4B MCPH1 DDX52 SKIL KIF2C | 6.80e-05 | 1294 | 60 | 10 | 30804502 |
| Pubmed | 7.96e-05 | 131 | 60 | 4 | 35356984 | ||
| Pubmed | 8.14e-05 | 8 | 60 | 2 | 22579593 | ||
| Pubmed | Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism. | 8.14e-05 | 8 | 60 | 2 | 12695355 | |
| Pubmed | 8.14e-05 | 8 | 60 | 2 | 18052087 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 1.08e-04 | 857 | 60 | 8 | 25609649 | |
| Pubmed | 1.27e-04 | 451 | 60 | 6 | 36168627 | ||
| Pubmed | 1.91e-04 | 486 | 60 | 6 | 20936779 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 2.70e-04 | 736 | 60 | 7 | 29676528 | |
| Pubmed | 3.52e-04 | 193 | 60 | 4 | 19343046 | ||
| Pubmed | 4.66e-04 | 208 | 60 | 4 | 11790298 | ||
| Pubmed | 5.28e-04 | 1084 | 60 | 8 | 11544199 | ||
| Pubmed | In silico QTL mapping of basal liver iron levels in inbred mouse strains. | 6.02e-04 | 21 | 60 | 2 | 21062905 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 6.50e-04 | 853 | 60 | 7 | 28718761 | |
| Pubmed | 6.61e-04 | 98 | 60 | 3 | 26561776 | ||
| Pubmed | 7.13e-04 | 233 | 60 | 4 | 37704626 | ||
| Pubmed | 7.23e-04 | 23 | 60 | 2 | 23790753 | ||
| Pubmed | Epithelial-derived gasdermin D mediates nonlytic IL-1β release during experimental colitis. | 7.23e-04 | 23 | 60 | 2 | 32597834 | |
| Pubmed | 7.85e-04 | 419 | 60 | 5 | 15635413 | ||
| Pubmed | 8.04e-04 | 638 | 60 | 6 | 33239621 | ||
| Pubmed | Redundant functions of RIM1alpha and RIM2alpha in Ca(2+)-triggered neurotransmitter release. | 9.26e-04 | 26 | 60 | 2 | 17124501 | |
| Pubmed | 1.08e-03 | 116 | 60 | 3 | 30652415 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 1.10e-03 | 678 | 60 | 6 | 30209976 | |
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | 1.33e-03 | 704 | 60 | 6 | 32994395 | |
| Pubmed | Association of mitotic regulation pathway polymorphisms with pancreatic cancer risk and outcome. | 1.40e-03 | 32 | 60 | 2 | 20056645 | |
| Pubmed | 1.53e-03 | 723 | 60 | 6 | 34133714 | ||
| Interaction | ANKRD20A4P interactions | 4.74e-07 | 6 | 59 | 3 | int:ANKRD20A4P | |
| Interaction | UGT2B28 interactions | 4.74e-07 | 6 | 59 | 3 | int:UGT2B28 | |
| Interaction | ANKRD20A2P interactions | 8.27e-07 | 7 | 59 | 3 | int:ANKRD20A2P | |
| Interaction | ANKRD20A1 interactions | 3.87e-06 | 11 | 59 | 3 | int:ANKRD20A1 | |
| Interaction | UGT2B10 interactions | 8.38e-05 | 5 | 59 | 2 | int:UGT2B10 | |
| Interaction | TNIP2 interactions | RPL10A PHF2 CASP8AP2 MVB12A ARID4B CLK3 TRO NCOA1 PDIA5 ZBTB18 HSP90AB1 | 8.60e-05 | 952 | 59 | 11 | int:TNIP2 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q13 | 6.25e-08 | 157 | 60 | 6 | chr4q13 | |
| Cytoband | 4q13 | 9.55e-07 | 15 | 60 | 3 | 4q13 | |
| Cytoband | 4q13.2 | 9.29e-06 | 31 | 60 | 3 | 4q13.2 | |
| Cytoband | 7p22 | 3.14e-04 | 20 | 60 | 2 | 7p22 | |
| Cytoband | 9p12 | 6.67e-04 | 29 | 60 | 2 | 9p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q21 | 2.29e-03 | 199 | 60 | 3 | chr9q21 | |
| Cytoband | 19p13.11 | 4.16e-03 | 73 | 60 | 2 | 19p13.11 | |
| GeneFamily | UDP glucuronosyltransferases | 9.38e-11 | 32 | 42 | 6 | 363 | |
| GeneFamily | Ankyrin repeat domain containing | 2.34e-04 | 242 | 42 | 5 | 403 | |
| Coexpression | VANLOO_SP3_TARGETS_DN | 1.21e-07 | 103 | 59 | 6 | MM919 | |
| Coexpression | WENG_POR_TARGETS_LIVER_UP | 1.28e-07 | 53 | 59 | 5 | MM1203 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_DN | 3.15e-07 | 121 | 59 | 6 | MM935 | |
| Coexpression | SERVITJA_LIVER_HNF1A_TARGETS_DN | 4.39e-06 | 190 | 59 | 6 | MM1311 | |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_DN | 6.06e-06 | 201 | 59 | 6 | MM1294 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP | 3.03e-05 | 267 | 59 | 6 | MM984 | |
| Coexpression | LUI_THYROID_CANCER_CLUSTER_3 | 3.41e-05 | 28 | 59 | 3 | M4290 | |
| Coexpression | BOCHKIS_FOXA2_TARGETS | 8.36e-05 | 467 | 59 | 7 | MM1233 | |
| Coexpression | GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP | 8.82e-05 | 200 | 59 | 5 | M4456 | |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4 | 9.78e-05 | 330 | 59 | 6 | MM1120 | |
| Coexpression | DESCARTES_ORGANOGENESIS_PRIMITIVE_ERYTHROID_LINEAGE | ANKRD20A4P CLK3 ANKRD20A3P ANKRD20A8P EIF2AK1 IL4I1 ANKRD20A1 | 1.23e-04 | 497 | 59 | 7 | MM3640 |
| Coexpression | LUI_THYROID_CANCER_PAX8_PPARG_DN | 1.54e-04 | 46 | 59 | 3 | M4902 | |
| ToppCell | Control-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 4.93e-06 | 184 | 60 | 5 | c6affa0b12510363258f65e46bf2d47bf4a8e75f | |
| ToppCell | COPD-Myeloid-cDC1|World / Disease state, Lineage and Cell class | 4.93e-06 | 184 | 60 | 5 | 42d7ce104cd7bcb83fbbbd0e7d3267ad07edfa94 | |
| ToppCell | IPF-Myeloid-cDC1|World / Disease state, Lineage and Cell class | 5.20e-06 | 186 | 60 | 5 | 962c2dada19185628ead77c32fcb07fa95114247 | |
| ToppCell | Control-Myeloid-cDC1|Control / Disease state, Lineage and Cell class | 5.20e-06 | 186 | 60 | 5 | b05c394aa3573ba855abc3066739ca193883b0c3 | |
| ToppCell | IPF-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 5.47e-06 | 188 | 60 | 5 | 47bb6caf84f70a1cda7d09803afdfd5182772e66 | |
| ToppCell | IPF-Myeloid-cDC1|IPF / Disease state, Lineage and Cell class | 5.47e-06 | 188 | 60 | 5 | 2331a2bae1383820d598e93aa86c75b101069bac | |
| ToppCell | COPD-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 5.91e-06 | 191 | 60 | 5 | 3480e6d27dd4291765bbbb2acdb6a2e4f02c8085 | |
| ToppCell | COPD-Myeloid-cDC1|COPD / Disease state, Lineage and Cell class | 6.06e-06 | 192 | 60 | 5 | bd3d00b094d92463b06023361a71240851a542b8 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like|GI_small-bowel / Manually curated celltypes from each tissue | 7.59e-05 | 167 | 60 | 4 | 3ae46c6363da76c8e1f5579e6027bf88ed637a44 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.13e-05 | 170 | 60 | 4 | ce2fd2fbbfd152290be0cf8e513f102fdc182b41 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.13e-05 | 170 | 60 | 4 | ab5c6a91c371e4df15b0842828dc55039695ab06 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_MYBPHL|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.13e-05 | 170 | 60 | 4 | 4aa9e597f6550ac8cac3137a98be58e71efd07d6 | |
| ToppCell | Basal_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 8.90e-05 | 174 | 60 | 4 | a0060be3940043015dcc49a5157de5541aed24a1 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.72e-05 | 178 | 60 | 4 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.06e-04 | 182 | 60 | 4 | 00a148b1e499bf16325491536d187d4dd6b70c06 | |
| ToppCell | Mesenchymal_cells-Osteoblasts|Mesenchymal_cells / Lineage and Cell class | 1.08e-04 | 183 | 60 | 4 | d6b52d52fe9a7a6c798947f05420d79fe12e4662 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 1.10e-04 | 184 | 60 | 4 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-ACTC+_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.10e-04 | 184 | 60 | 4 | 39168ca2bbf1369c9fe87c67f0aaff5e3cd03151 | |
| ToppCell | Control-Myeloid-cDC1|World / Disease state, Lineage and Cell class | 1.15e-04 | 186 | 60 | 4 | 3de803dee3ef10eb85a2b47d3f93385214e5b0ff | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 186 | 60 | 4 | 32d30f08b20a0a28e38b37bd52ab26d1d43736ce | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.15e-04 | 186 | 60 | 4 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.15e-04 | 186 | 60 | 4 | aed57d1498fae4abe708aaad210900f2db2a189c | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 187 | 60 | 4 | 1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.17e-04 | 187 | 60 | 4 | edb0ab0154542b1c0b3a2c216c4a60f0f06290b3 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.22e-04 | 189 | 60 | 4 | 7899af78b273d9c7f029d52f7e0cf6df4da41f5e | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.25e-04 | 190 | 60 | 4 | a34293601aefe5fb5c400c14091294b9ddaa195b | |
| ToppCell | 10x5'-Liver-Myeloid_Mac-Macrophage|Liver / Manually curated celltypes from each tissue | 1.27e-04 | 191 | 60 | 4 | bd7fd445e3d6316d0336c109889e7e6dc394a55e | |
| ToppCell | mLN-(5)_Dendritic_cell-(53)_Lymphoid_DC|mLN / shred on region, Cell_type, and subtype | 1.46e-04 | 198 | 60 | 4 | da84c76afe835aeee39da04b63c03549218b5d91 | |
| ToppCell | mLN-Dendritic_cell-Lymphoid_DC|mLN / Region, Cell class and subclass | 1.46e-04 | 198 | 60 | 4 | 3965a9f1e8a51a196e5349aaca5fa5ed1cd8ee92 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 1.49e-04 | 199 | 60 | 4 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 1.49e-04 | 199 | 60 | 4 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| Computational | Steroid hormone and heme metabolism. | 1.48e-07 | 16 | 34 | 4 | MODULE_505 | |
| Computational | Genes in the cancer module 227. | 1.28e-05 | 15 | 34 | 3 | MODULE_227 | |
| Drug | C1 11-32 | 3.80e-12 | 18 | 58 | 6 | CID000443077 | |
| Drug | C11131 | 3.80e-12 | 18 | 58 | 6 | CID000443076 | |
| Drug | T4-G | 5.54e-12 | 19 | 58 | 6 | CID000152424 | |
| Drug | estriol-16-glucuronide | 1.10e-11 | 21 | 58 | 6 | CID000122281 | |
| Drug | estradiol-3-glucuronide | 2.04e-11 | 23 | 58 | 6 | CID000066651 | |
| Drug | L-idaro-1,4-lactone | 7.55e-11 | 28 | 58 | 6 | CID000078997 | |
| Drug | 7-hydroxycoumarin glucuronide | 9.51e-11 | 29 | 58 | 6 | CID000125641 | |
| Drug | phenolphthalein | 1.30e-10 | 58 | 58 | 7 | CID000004764 | |
| Drug | AC1Q6OQG | 2.20e-10 | 33 | 58 | 6 | CID000009686 | |
| Drug | BP-3,6-quinol | 2.20e-10 | 33 | 58 | 6 | CID000119292 | |
| Drug | AC1NOWCJ | 3.21e-10 | 35 | 58 | 6 | CID005120112 | |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | 3.21e-10 | 35 | 58 | 6 | CID010436171 | |
| Drug | estrone-3-glucuronide | 3.21e-10 | 35 | 58 | 6 | CID000115255 | |
| Drug | l-borneol | 4.58e-10 | 37 | 58 | 6 | CID000010049 | |
| Drug | fibrates | ARID4B UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B28 EIF2AK1 UGT2B11 | 6.32e-10 | 118 | 58 | 8 | CID000002797 |
| Drug | harmol | 7.52e-10 | 40 | 58 | 6 | CID000068094 | |
| Drug | 7-hydroxycoumarin | 8.31e-10 | 75 | 58 | 7 | CID005281426 | |
| Drug | testosterone glucuronide | 8.79e-10 | 41 | 58 | 6 | CID000108192 | |
| Drug | 2-AF | 8.79e-10 | 41 | 58 | 6 | CID000005800 | |
| Drug | 16-epiestriol | 1.00e-09 | 77 | 58 | 7 | CID000003269 | |
| Drug | androsterone glucuronide | 1.19e-09 | 43 | 58 | 6 | CID000114833 | |
| Drug | 7,8-benzoquinoline | 1.19e-09 | 43 | 58 | 6 | CID000009191 | |
| Drug | MS-222 | 1.37e-09 | 44 | 58 | 6 | CID000011400 | |
| Drug | 5 alpha-androstane | 1.86e-09 | 84 | 58 | 7 | CID000094144 | |
| Drug | salicylamide | 2.37e-09 | 48 | 58 | 6 | CID000005147 | |
| Drug | menthol | 2.39e-09 | 87 | 58 | 7 | CID000001254 | |
| Drug | AC1NQGK1 | 3.89e-09 | 52 | 58 | 6 | CID005195977 | |
| Drug | oxazepam | 4.38e-09 | 53 | 58 | 6 | CID000004616 | |
| Drug | 7-methoxycoumarin | 6.87e-09 | 57 | 58 | 6 | CID000010748 | |
| Drug | urochloralic acid | 8.50e-09 | 59 | 58 | 6 | CID003036914 | |
| Drug | 4-hydroxybiphenyl | 8.50e-09 | 59 | 58 | 6 | CID000007103 | |
| Drug | 4-hydroxyestrone | 8.50e-09 | 59 | 58 | 6 | CID000018418 | |
| Drug | acetaminophen glucuronide | 8.50e-09 | 59 | 58 | 6 | CID000083944 | |
| Drug | SN-38G | 8.50e-09 | 59 | 58 | 6 | CID000443154 | |
| Drug | UDP-alpha-d-xylopyranose | 9.43e-09 | 60 | 58 | 6 | CID000001165 | |
| Drug | 3-OHBaP | 1.27e-08 | 63 | 58 | 6 | CID000025890 | |
| Drug | lithocholic acid | 1.80e-08 | 116 | 58 | 7 | CID000009903 | |
| Drug | Meldola | 2.03e-08 | 68 | 58 | 6 | CID000081507 | |
| Drug | methoxyresorufin | 2.22e-08 | 69 | 58 | 6 | CID000119220 | |
| Drug | 2,2,2-trichloroethanol | 3.13e-08 | 73 | 58 | 6 | CID000008259 | |
| Drug | eugenol | 3.13e-08 | 73 | 58 | 6 | CID000003314 | |
| Drug | AC1N8H7N | 4.67e-08 | 78 | 58 | 6 | CID004318740 | |
| Drug | benzyloxyresorufin | 4.67e-08 | 78 | 58 | 6 | CID000114982 | |
| Drug | acridine | 5.87e-08 | 81 | 58 | 6 | CID000009215 | |
| Drug | 7-ethoxycoumarin | 8.41e-08 | 86 | 58 | 6 | CID000035703 | |
| Drug | pentoxyresorufin | 9.02e-08 | 87 | 58 | 6 | CID000107683 | |
| Drug | 4-aminobiphenyl | 1.26e-07 | 92 | 58 | 6 | CID000007102 | |
| Drug | p-nitroanisole | 1.26e-07 | 92 | 58 | 6 | CID000007485 | |
| Drug | 2-naphthol | 1.35e-07 | 93 | 58 | 6 | CID000008663 | |
| Drug | disulfiram | 1.52e-07 | 158 | 58 | 7 | CID000003117 | |
| Drug | DCNB | 1.53e-07 | 95 | 58 | 6 | CID000007443 | |
| Drug | ethoxyresorufin | 1.53e-07 | 95 | 58 | 6 | CID000003294 | |
| Drug | Amobarbital | 1.56e-07 | 5 | 58 | 3 | ctd:D000654 | |
| Drug | phenolphthalin | 1.56e-07 | 5 | 58 | 3 | CID000066494 | |
| Drug | DB04103 | 1.73e-07 | 97 | 58 | 6 | CID004469987 | |
| Drug | 1-naphthol | 1.84e-07 | 98 | 58 | 6 | CID000007005 | |
| Drug | al-Badry | 2.04e-07 | 165 | 58 | 7 | CID000004545 | |
| Drug | 3-hydroxyandrostan-17-one | 2.34e-07 | 102 | 58 | 6 | CID000000225 | |
| Drug | chrysin | 2.94e-07 | 106 | 58 | 6 | CID005281607 | |
| Drug | fluconazole | 3.10e-07 | 107 | 58 | 6 | CID000003365 | |
| Drug | 2-hydroxyestriol | 3.12e-07 | 6 | 58 | 3 | CID000014688 | |
| Drug | 2-naphthylamine | 3.66e-07 | 110 | 58 | 6 | CID000007057 | |
| Drug | Hymecromone | 4.61e-07 | 25 | 58 | 4 | ctd:D006923 | |
| Drug | ethoxyquin | 5.01e-07 | 116 | 58 | 6 | CID000003293 | |
| Drug | uridine 5'-diphosphoglucuronic acid | 5.11e-07 | 189 | 58 | 7 | CID000000390 | |
| Drug | AC1Q7AUJ | 5.27e-07 | 117 | 58 | 6 | CID000003303 | |
| Drug | ranirestat | 5.45e-07 | 7 | 58 | 3 | ctd:C115070 | |
| Drug | alpha-naphthoflavone | 5.54e-07 | 118 | 58 | 6 | CID000011790 | |
| Drug | benzphetamine | 5.82e-07 | 119 | 58 | 6 | CID000002341 | |
| Drug | hexobarbital | 8.54e-07 | 127 | 58 | 6 | CID000003608 | |
| Drug | AC1L1FK5 | 9.36e-07 | 129 | 58 | 6 | CID000003272 | |
| Drug | 4-methylumbelliferone | 1.07e-06 | 132 | 58 | 6 | CID003364573 | |
| Drug | NNAL | 1.29e-06 | 32 | 58 | 4 | CID000104856 | |
| Drug | oltipraz | 1.33e-06 | 137 | 58 | 6 | CID000047318 | |
| Drug | aniline | 1.64e-06 | 142 | 58 | 6 | CID000006115 | |
| Drug | butylated hydroxytoluene | 1.71e-06 | 143 | 58 | 6 | CID000031404 | |
| Drug | 2 E1 | 1.85e-06 | 145 | 58 | 6 | CID006102788 | |
| Drug | 1,4-benzodiazepine | 2.55e-06 | 11 | 58 | 3 | CID000148431 | |
| Drug | UDP-glucose | 3.05e-06 | 247 | 58 | 7 | CID000001166 | |
| Drug | 4-hydroxyestrone | 3.40e-06 | 12 | 58 | 3 | ctd:C026418 | |
| Drug | AC1LCF1F | 3.40e-06 | 161 | 58 | 6 | CID000627275 | |
| Drug | AC1L7AJI | 3.86e-06 | 256 | 58 | 7 | CID000003750 | |
| Drug | PTBP | 3.95e-06 | 42 | 58 | 4 | CID000007393 | |
| Drug | estrone-d4 | 4.35e-06 | 168 | 58 | 6 | CID000000698 | |
| Drug | cotinine-N-glucuronide | 4.41e-06 | 13 | 58 | 3 | CID000000411 | |
| Drug | 2-acetylaminofluorene | 4.49e-06 | 262 | 58 | 7 | CID000005897 | |
| Drug | aminopyrine | 4.81e-06 | 171 | 58 | 6 | CID000006009 | |
| Drug | glucosiduronate | 4.81e-06 | 171 | 58 | 6 | CID000000610 | |
| Drug | 4-nitrophenol | 5.87e-06 | 177 | 58 | 6 | CID000000980 | |
| Drug | 2-hydroxyestriol | 6.38e-06 | 2 | 58 | 2 | ctd:C008012 | |
| Drug | SN-38 | 7.33e-06 | 184 | 58 | 6 | CID000104842 | |
| Drug | pheophytin | 7.62e-06 | 284 | 58 | 7 | CID000000250 | |
| Drug | silibinin | 7.79e-06 | 285 | 58 | 7 | CID000005213 | |
| Drug | DNCB | 8.55e-06 | 189 | 58 | 6 | CID000000006 | |
| Drug | dimethylnitrosamine | 1.05e-05 | 196 | 58 | 6 | CID000006124 | |
| Drug | 2-butyl-6-methoxyphenol | 1.08e-05 | 197 | 58 | 6 | CID011954184 | |
| Drug | beta-naphthoflavone | 1.18e-05 | 200 | 58 | 6 | CID000002361 | |
| Drug | UDP-N-acetylglucosamine | 1.28e-05 | 203 | 58 | 6 | CID000001167 | |
| Drug | clofibrate | 1.37e-05 | 311 | 58 | 7 | CID000002796 | |
| Drug | Aroclor 1254 | 1.69e-05 | 213 | 58 | 6 | CID000040470 | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 2.13e-12 | 9 | 54 | 5 | EFO_0600040 | |
| Disease | X-19141 measurement | 7.07e-09 | 13 | 54 | 4 | EFO_0800799 | |
| Disease | X-24947 measurement | 7.15e-08 | 22 | 54 | 4 | EFO_0800910 | |
| Disease | vanillylmandelate (VMA) measurement | 2.02e-07 | 7 | 54 | 3 | EFO_0800119 | |
| Disease | deoxycholic acid glucuronide measurement | 3.22e-07 | 8 | 54 | 3 | EFO_0800575 | |
| Disease | X-12007 measurement | 3.29e-06 | 2 | 54 | 2 | EFO_0021276 | |
| Disease | phosphatidylcholine 36:4 measurement | 4.64e-06 | 18 | 54 | 3 | EFO_0010382 | |
| Disease | serum clozapine-to-N-desmethylclozapine ratio measurement | 9.85e-06 | 3 | 54 | 2 | EFO_0600042 | |
| Disease | X-16576 measurement | 1.97e-05 | 4 | 54 | 2 | EFO_0800760 | |
| Disease | vitamin D deficiency | 4.31e-05 | 37 | 54 | 3 | EFO_0003762 | |
| Disease | cotinine measurement, trans-3-hydroxycotinine measurement | 4.91e-05 | 6 | 54 | 2 | EFO_0007813, EFO_0010707 | |
| Disease | cortolone glucuronide (1) measurement | 4.91e-05 | 6 | 54 | 2 | EFO_0800552 | |
| Disease | X-24418 measurement | 6.86e-05 | 7 | 54 | 2 | EFO_0800879 | |
| Disease | metabolite measurement | 6.99e-05 | 560 | 54 | 7 | EFO_0004725 | |
| Disease | urinary metabolite measurement | 8.60e-05 | 245 | 54 | 5 | EFO_0005116 | |
| Disease | serum N-desmethylclozapine measurement | 9.14e-05 | 8 | 54 | 2 | EFO_0600043 | |
| Disease | X-12844 measurement | 1.17e-04 | 9 | 54 | 2 | EFO_0021339 | |
| Disease | plasma N-desmethylclozapine measurement | 1.79e-04 | 11 | 54 | 2 | EFO_0600039 | |
| Disease | disease progression measurement | 1.93e-04 | 61 | 54 | 3 | EFO_0008336 | |
| Disease | cotinine glucuronidation measurement | 5.51e-04 | 19 | 54 | 2 | EFO_0006508 | |
| Disease | androsterone glucuronide measurement | 6.12e-04 | 20 | 54 | 2 | EFO_0800317 | |
| Disease | cotinine measurement | 8.11e-04 | 23 | 54 | 2 | EFO_0007813 | |
| Disease | docosahexaenoic acid measurement | 1.65e-03 | 127 | 54 | 3 | EFO_0007761 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CKKEKMVEFLLKKKA | 176 | Q5TYW2 | |
| KKEEKAKNKESLCME | 841 | Q4LE39 | |
| KCFLEKAKDKQKKVT | 571 | Q9Y2R4 | |
| CKKEKMVEFLLKKKA | 176 | Q5CZ79 | |
| LIICCVKKKKKKTNK | 686 | Q9H5V8 | |
| CKKEKMVEFLLKKKA | 176 | Q4UJ75 | |
| QMKKKFCVLKKKLSE | 991 | Q9BXX3 | |
| IKEKDKENKFLCVLM | 356 | P49761 | |
| GKCQLQMKELMKKFK | 81 | Q9UKL3 | |
| KLYQMNDLCIEKKKL | 1766 | Q96MT7 | |
| KSKKKEKEMADQTCI | 131 | Q6ZS30 | |
| KKEECLKMESQLKKA | 706 | Q8IUD2 | |
| CKKEKMVEFLLKRKA | 176 | Q5SQ80 | |
| KKMEESKAKFENLCK | 551 | P08238 | |
| SKAKFENLCKLMKEI | 556 | P08238 | |
| KELKVAMKKTCFTKL | 296 | Q8NGA6 | |
| AHKVCVKEIKRLKKM | 286 | Q86WA8 | |
| SSLIKKKRKCMQPKD | 101 | Q8NEM0 | |
| VKLYLMKKLKEVTDK | 166 | A8MVJ9 | |
| VEKKTVTMIVDCKKK | 171 | P12107 | |
| SKKKCSDLTLEEMKK | 96 | Q92628 | |
| VKLFKQEKKMQCKKH | 191 | Q9Y616 | |
| IKKEIQDMLKKFFCK | 461 | Q96P66 | |
| KVRAKICKMKVTTKV | 116 | F8WFD2 | |
| KNLLIMCKEKEKLQK | 176 | Q9BT25 | |
| KASVSKKKRMCVKLL | 96 | Q96EY5 | |
| IKTELCKKEVLNMLK | 1041 | Q92896 | |
| CKKEKMVEFLLKRKA | 176 | Q5VUR7 | |
| KKILIKGATKTVCMK | 196 | Q9BQI3 | |
| KSCLVKEVEKMKNKR | 191 | Q99661 | |
| QKTQVKCRKILTKMK | 181 | P0C7I6 | |
| RKLCKKMKVDLSPKD | 91 | Q14554 | |
| LKDLKALGCRKAMKK | 191 | Q96RQ9 | |
| AKKNFDKLKMDVCQK | 201 | Q05084 | |
| NKRCKDKKKSILMKQ | 241 | Q96A47 | |
| KLTVCILEAKNLKKM | 286 | Q8N9I0 | |
| LKNLCSKTIGEKMKK | 56 | P49591 | |
| NPEKMKELKKICKSS | 21 | Q2YD98 | |
| VTDVTKQKDCKMKLK | 161 | O75151 | |
| KDLEKKLEQIMKQKC | 601 | P12757 | |
| MKTVKEKKECQRLRK | 1 | Q9BWX1 | |
| TDKMVKKLIEKFQKC | 396 | Q9P289 | |
| KCKILKKTVDQIQLM | 66 | Q15788 | |
| LMKKIILEFKEKCKD | 2016 | Q7Z333 | |
| LCFLQDKKMFKSVVK | 186 | Q9BQ13 | |
| CVTMSKKLLIEKSKQ | 266 | Q86UE8 | |
| KKLLIEKSKQEKMAC | 271 | Q86UE8 | |
| TMLKLIQKKLLDKTC | 526 | Q7Z7L7 | |
| KDLKQTMKKEQCEVK | 1971 | Q8N2C7 | |
| LVLEAKKCVKKMNKS | 76 | P0CB47 | |
| KEEKLMKICKIKNLS | 1546 | Q9BX84 | |
| SKMKVLKFACRVQKK | 616 | Q12816 | |
| FCKDIVSNKKLMKKL | 126 | P06133 | |
| MYDIVKVCKKKLKEK | 106 | Q99592 | |
| CKKLTKLAKENDSMK | 161 | O94964 | |
| FCKDVVSNKKVMKKL | 126 | O75310 | |
| VKSTIKFQMKKVLCL | 151 | P62906 | |
| CKDVVSNKKLMKKLQ | 126 | P36537 | |
| KLCKDAVLNKKLMMK | 126 | P54855 | |
| FCKDVVSNKKVMKKL | 126 | Q9BY64 | |
| FCILSKKEIQKKMDK | 306 | Q9UNX4 | |
| FCKDVVSNKKFMKKV | 126 | P16662 | |
| FTKCLKMLQKKIEEK | 101 | Q9H3S4 | |
| ETCKNKKTMEAKIKQ | 1006 | Q9C099 |